pfizer

Use according to the manufacturer's instructions and applicable procedure. Browse related Sodium Chloride Injection.

Pfizer Bacteriostatic Sodium Chloride Injection in Canada

Pfizer 0.9% Bacteriostatic Sodium Chloride Injection is a sterile solution for injection. Health Canada lists Pfizer Canada ULC as the manufacturer. The product is marketed under DIN 00037818.

The solution contains sodium chloride 9mg/mL, equivalent to 0.9% sodium chloride. Health Canada lists intramuscular, subcutaneous, and intravenous administration routes.

Pfizer describes bacteriostatic 0.9% Sodium Chloride Injection as a sterile, nonpyrogenic, isotonic solution. It contains water for injection and a bacteriostatic preservative. The preservative is benzyl alcohol.

This product is intended for parenteral use after adding medications that require dilution. It can also dissolve medications requiring an aqueous vehicle before injection.

Key Features

Common Applications

Pfizer Bacteriostatic Sodium Chloride Injection 10mL is used as a diluent. It supports medications requiring dilution or dissolution before injection.

Health Canada lists the product for intramuscular, subcutaneous, and intravenous administration. Healthcare professionals should determine suitability based on the medication and clinical requirements.

The multiple-dose container allows repeated withdrawals when used according to applicable instructions. Pfizer specifies that the preparation is intended for parenteral use after appropriate medication addition.

Product Specifications